HRTS vs. PBPH
HRTS (Tema Obesity & Cardiometabolic ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds. HRTS is actively managed, while PBPH is passively managed. Their correlation of 0.92 suggests significant overlap in exposure. HRTS charges 0.75%/yr vs 0.13%/yr for PBPH.
Performance
HRTS vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HRTS achieves a -5.70% return, which is significantly lower than PBPH's -1.13% return.
HRTS
- 1D
- 0.51%
- 1M
- -0.90%
- YTD
- -5.70%
- 6M
- -5.48%
- 1Y
- 20.97%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HRTS vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
HRTS Tema Obesity & Cardiometabolic ETF | -5.70% | 0.10% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between HRTS and PBPH is 0.92, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.92 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HRTS vs. PBPH — Risk / Return Rank
HRTS
PBPH
HRTS vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HRTS | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.23 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.91 | — | — |
| Martin ratioReturn relative to average drawdown | 4.83 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HRTS | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.55 | -0.04 | +0.60 |
Drawdowns
HRTS vs. PBPH - Drawdown Comparison
The maximum HRTS drawdown since its inception was -25.81%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for HRTS and PBPH.
Loading charts...
Drawdown Indicators
| HRTS | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.81% | -11.10% | -14.71% |
Max Drawdown (1Y)Largest decline over 1 year | -11.01% | — | — |
Current DrawdownCurrent decline from peak | -9.14% | -8.69% | -0.45% |
Average DrawdownAverage peak-to-trough decline | -9.02% | -4.23% | -4.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.36% | — | — |
Volatility
HRTS vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| HRTS | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.44% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 11.26% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 16.03% | 16.78% | -0.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.07% | 16.78% | +2.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.07% | 16.78% | +2.29% |
HRTS vs. PBPH - Expense Ratio Comparison
HRTS has a 0.75% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
HRTS vs. PBPH - Dividend Comparison
HRTS's dividend yield for the trailing twelve months is around 1.42%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
HRTS Tema Obesity & Cardiometabolic ETF | 1.42% | 1.34% | 1.63% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% |
Frequently Asked Questions
With a correlation of 0.92, HRTS and PBPH move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.75% for HRTS.
HRTS has the higher dividend yield at 1.42%, compared with 0.09% for PBPH.
They also come from different issuers: Tema and Portfolio Building Block. Their fees differ too: 0.75% for HRTS and 0.13% for PBPH.
Find the right allocation for HRTS and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer